XBiotech Stock (NASDAQ:XBIT)


RevenueOwnershipFinancialsChart

Previous Close

$6.38

52W Range

$3.51 - $9.96

50D Avg

$7.07

200D Avg

$7.11

Market Cap

$137.18M

Avg Vol (3M)

$53.13K

Beta

1.41

Div Yield

-

XBIT Company Profile


XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

82

IPO Date

Apr 15, 2015

Website

XBIT Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 22Dec 21Dec 20
Clinical Trial Service Revenue-$394.00K$25.98M
Manufacturing Revenue$4.01M$18.00M$18.00M
Product and Service, Other--$22.00K

Fiscal year ends in Dec 23 | Currency in USD

XBIT Financial Summary


Dec 23Dec 22Dec 21
Revenue-$4.01M$18.39M
Operating Income$-37.51M$-34.49M$-25.08M
Net Income$-24.56M$-32.90M$-17.41M
EBITDA$-37.51M$-29.08M$-21.72M
Basic EPS$-0.81$-1.08$-0.58
Diluted EPS$-0.81$-1.08$-0.58

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q1 17May 07, 17 | 12:51 PM
Q4 16Mar 16, 17 | 11:00 AM
Q3 16Nov 15, 16 | 1:02 PM

Peer Comparison


TickerCompany
DAWNDay One Biopharmaceuticals, Inc.
PHATPhathom Pharmaceuticals, Inc.
STOKStoke Therapeutics, Inc.
ERASErasca, Inc.
GBIOGeneration Bio Co.
ABSIAbsci Corporation
REPLReplimune Group, Inc.
KRONKronos Bio, Inc.
INZYInozyme Pharma, Inc.
XFORX4 Pharmaceuticals, Inc.
EWTXEdgewise Therapeutics, Inc.
ONCTOncternal Therapeutics, Inc.
TSVT2seventy bio, Inc.
CCCCC4 Therapeutics, Inc.
ELDNEledon Pharmaceuticals, Inc.
ADVMAdverum Biotechnologies, Inc.
ABOSAcumen Pharmaceuticals, Inc.
KZRKezar Life Sciences, Inc.
PASGPassage Bio, Inc.